Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
Status PubMed-not-MEDLINE Language English Country Netherlands Media print
Document type Published Erratum
PubMed
35174440
PubMed Central
PMC9015977
DOI
10.1007/s10875-022-01219-3
PII: 10.1007/s10875-022-01219-3
Knihovny.cz E-resources
- Publication type
- Published Erratum MeSH
Asklepios Kinderklinik Sankt Augustin Sankt Augustin Germany
Department of Immunology and Allergy The Royal Melbourne Hospital Melbourne VIC Australia
Department of Immunology Children's Memorial Health Institute Warsaw Poland
Department of Immunology Sullivan Nicolaides Pathology Brisbane QLD Australia
Department of Immunology The Royal London Hospital Barts Health NHS Trust London UK
Department of Medicine The University of Melbourne Melbourne VIC Australia
Department of Medicine University of Cambridge Cambridge UK
Grifols Bioscience Industrial Group Sant Cugat del Vallès Barcelona Spain
Grifols Bioscience R and D Research Triangle Park NC USA
Institut de Recerca Sant Joan de Déu Barcelona Spain
Klinikum St Georg GmbH Klinik für Kinder und Jugendmedizin Leipzig Germany
Peninsula Immunology and Allergy Service University Hospitals Plymouth Plymouth UK
Servicio de Inmunología Hospital Clínico San Carlos Madrid Spain
References provided by Crossref.org